Trubridge, Inc. ( (TBRG) ) has released its Q2 earnings. Here is a breakdown of the information Trubridge, Inc. presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
TruBridge, Inc. is a healthcare solutions company that provides technology, services, and strategic expertise to support rural and community hospitals in the United States. With over 45 years of experience, the company focuses on revenue cycle management, electronic health records, and analytics to help healthcare providers remain independent and community-focused.
In its second quarter of 2025, TruBridge reported steady financial performance with total revenue of $85.7 million, slightly up from $85.6 million in the same quarter of the previous year. The company also saw a significant turnaround in profitability, reporting a GAAP net income of $2.6 million compared to a net loss of $4.4 million in the prior year.
Key financial highlights include a 10% increase in total bookings to $25.6 million and a notable improvement in non-GAAP net income, which rose to $7.9 million from $3.0 million. Adjusted EBITDA also saw a slight increase to $13.7 million. The company’s recurring revenue accounted for 95% of total revenue, underscoring its stable income stream.
Despite a slight decrease in Financial Health revenue, the company remains optimistic about its strategic initiatives, including offshoring and resource management improvements, which have led to cost efficiencies. TruBridge has adjusted its full-year revenue outlook to reflect client attrition and the complexity of new deals but has raised its Adjusted EBITDA forecast, indicating confidence in its operational efficiencies.
Looking ahead, TruBridge’s management is focused on enhancing client satisfaction and optimizing its business approach to ensure long-term success. The company expects to generate total revenue between $345 million and $350 million for the full year 2025, with an Adjusted EBITDA range of $62 million to $67 million.